Overview

Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy

Status:
Recruiting
Trial end date:
2027-02-15
Target enrollment:
Participant gender:
Summary
Patients older than ≥18 years, with muscle-invasive bladder cancer unfit for radical cystectomy because of age, comorbidities, and/or patient's refusal. This study is designed as a multicentre, single-arm phase II study.
Phase:
Phase 2
Details
Lead Sponsor:
UNICANCER
Collaborator:
Roche Pharma AG
Treatments:
Antibodies, Monoclonal
Atezolizumab